CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -66.7% | 500 | -52.4% | 0.00% | – |
| Q2 2017 | $3,000 | -25.0% | 1,050 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | -90.5% | 1,050 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $42,000 | -61.1% | 1,050 | -95.7% | 0.00% | -92.3% |
| Q2 2016 | $108,000 | +13.7% | 24,500 | -2.0% | 0.01% | +8.3% |
| Q1 2016 | $95,000 | -75.3% | 25,000 | +2.0% | 0.01% | -75.5% |
| Q4 2015 | $384,000 | +69.2% | 24,500 | +12.7% | 0.05% | +63.3% |
| Q3 2015 | $227,000 | -59.2% | 21,740 | -1.4% | 0.03% | -55.9% |
| Q2 2015 | $556,000 | -14.2% | 22,040 | -5.2% | 0.07% | -11.7% |
| Q1 2015 | $648,000 | +52.8% | 23,240 | 0.0% | 0.08% | +51.0% |
| Q4 2014 | $424,000 | -3.6% | 23,240 | -31.5% | 0.05% | -3.8% |
| Q3 2014 | $440,000 | -24.7% | 33,940 | -5.2% | 0.05% | -25.4% |
| Q2 2014 | $584,000 | -21.6% | 35,790 | -15.1% | 0.07% | -22.8% |
| Q1 2014 | $745,000 | -30.7% | 42,140 | -5.1% | 0.09% | -34.3% |
| Q4 2013 | $1,075,000 | -31.7% | 44,420 | 0.0% | 0.14% | -36.1% |
| Q3 2013 | $1,574,000 | +127.1% | 44,420 | 0.0% | 0.22% | +119.0% |
| Q2 2013 | $693,000 | – | 44,420 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |